Horga Maria Arantxa has filed 17 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 173500 shares of Atea Pharmaceuticals, Inc. ($AVIR) on January 31, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 31, 2026 | Atea Pharmaceuticals, Inc. | $AVIR | Horga Maria Arantxa | Chief Medical Officer | A | Stock Option (Right to Buy) | 173500 | $0.00 | 173,500.0000 | 78,126,796 | 9999.99% | 0.22% |
| Jan. 31, 2026 | Atea Pharmaceuticals, Inc. | $AVIR | Horga Maria Arantxa | Chief Medical Officer | M | Restricted Stock Units | 9750 | $0.00 | 0.0000 | 78,126,796 | 100.00% | 0.01% |
| Jan. 31, 2026 | Atea Pharmaceuticals, Inc. | $AVIR | Horga Maria Arantxa | Chief Medical Officer | M | Restricted Stock Units | 41533 | $0.00 | 0.0000 | 78,126,796 | 100.00% | 0.05% |
| Jan. 31, 2026 | Atea Pharmaceuticals, Inc. | $AVIR | Horga Maria Arantxa | Chief Medical Officer | F | Common Stock | 16073 | $4.24 | 96,086.0000 | 78,126,796 | 14.33% | 0.02% |
| Jan. 31, 2026 | Atea Pharmaceuticals, Inc. | $AVIR | Horga Maria Arantxa | Chief Medical Officer | M | Common Stock | 51283 | $0.00 | 112,159.0000 | 78,126,796 | 84.24% | 0.07% |
| Jan. 31, 2025 | Atea Pharmaceuticals, Inc. | $AVIR | Horga Maria Arantxa | Chief Medical Officer | A | Stock Option (Right to Buy) | 192800 | $0.00 | 192,800.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2025 | Atea Pharmaceuticals, Inc. | $AVIR | Horga Maria Arantxa | Chief Medical Officer | M | Common Stock | 41533 | $0.00 | 67,197.0000 | 0 | 161.83% | 0.00% |
| Jan. 31, 2025 | Atea Pharmaceuticals, Inc. | $AVIR | Horga Maria Arantxa | Chief Medical Officer | A | Common Stock | 9750 | $0.00 | 76,947.0000 | 0 | 14.51% | 0.00% |
| Jan. 31, 2025 | Atea Pharmaceuticals, Inc. | $AVIR | Horga Maria Arantxa | Chief Medical Officer | F | Common Stock | 16071 | $3.06 | 60,876.0000 | 0 | 20.89% | 0.00% |
| Jan. 31, 2025 | Atea Pharmaceuticals, Inc. | $AVIR | Horga Maria Arantxa | Chief Medical Officer | M | Restricted Stock Units | 41533 | $0.00 | 41,533.0000 | 0 | 50.00% | 0.00% |
| Jan. 31, 2025 | Atea Pharmaceuticals, Inc. | $AVIR | Horga Maria Arantxa | Chief Medical Officer | A | Restricted Stock Units | 9750 | $0.00 | 9,750.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Atea Pharmaceuticals, Inc. | $AVIR | Horga Maria Arantxa | Chief Medical Officer | A | Stock Option (Right to Buy) | 192800 | $0.00 | 192,800.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Atea Pharmaceuticals, Inc. | $AVIR | Horga Maria Arantxa | Chief Medical Officer | M | Restricted Stock Units | 41534 | $0.00 | 83,066.0000 | 0 | 33.33% | 0.00% |
| Feb. 1, 2024 | Atea Pharmaceuticals, Inc. | $AVIR | Horga Maria Arantxa | Chief Medical Officer | S | Common Stock | 15870 | $3.84 | 25,664.0000 | 0 | 38.21% | 0.00% |
| Jan. 31, 2024 | Atea Pharmaceuticals, Inc. | $AVIR | Horga Maria Arantxa | Chief Medical Officer | M | Common Stock | 41534 | $0.00 | 41,534.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2023 | Atea Pharmaceuticals, Inc. | $AVIR | Horga Maria Arantxa | Chief Medical Officer | A | Stock Option (Right to Buy) | 174500 | $0.00 | 174,500.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2023 | Atea Pharmaceuticals, Inc. | $AVIR | Horga Maria Arantxa | Chief Medical Officer | A | Restricted Stock Units | 124600 | $0.00 | 124,600.0000 | 0 | 9999.99% | 0.00% |